Hattori, Masaya http://orcid.org/0000-0002-0935-9269
Hagiwara, Sumitaka
Kotani, Haruru
Tatematsu, Michiko
Tachi, Masahiko
Hijioka, Susumu
Shimizu, Junichi
Andoh, Masashi
Mizuno, Yasunari
Sawaki, Masataka
Yoshimura, Akiyo
Gondo, Naomi
Adachi, Yayoi
Yoshimura, Kenichi
Iwata, Hiroji
Article History
Received: 30 March 2019
Accepted: 21 May 2019
First Online: 1 June 2019
Compliance with ethical standards
:
: Masaya Hattori received honoraria from Chugai Pharmaceutical, Eli Lilly Japan, Novartis Pharma, AstraZeneca, Pfizer Japan, and Eisai for work performed outside of the current study. Susumu Hijioka received honoraria from Novel Pharma, Novartis Pharma, and Tenjin Pharma for work performed outside of the current study. Hiroji Iwata received research funding from Chugai Pharmaceutical, MSD K.K, Eli Lilly Japan, and Novartis Pharma for work performed outside of the current study; received honoraria from Chugai Pharmaceutical, Daiichi Sankyo, and AstraZeneca for work performed outside of the current study; and is a member of scientific advisory board of Daiichi Sankyo, Chugai Pharmaceutical, Eli Lilly Japan, Kyowa Hakko Kirin, Pfizer Japan, Novartis Pharma, and AstraZeneca for work performed outside of the current study. The other authors have no conflicts of interest to declare.